Search results for Golimumab ELISA Kit
Golimumab ELISA Kit, ProteoGenix, KPTX129
Description of Golimumab ELISA Kit Golimumab ELISA Kit: A Powerful Tool for Detecting and Quantifying Golimumab in Biological Samples Golimumab is a monoclonal antibody that has been developed as a therapeutic agent for treating autoimmune disorders such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It works by binding to a specific protein called tumor necrosis factor alpha (TNF-α), which plays a key role in the inflammatory response. By blocking the action of TNF-α, golimumab helps reduce inflammation and alleviate symptoms of these diseases. As with any therapeutic agent, it is important to accurately measure the levels of golimumab in a patient’s body to ensure proper dosing and treatment efficacy. This is where the Golimumab ELISA Kit comes into play. ELISA (enzyme-linked immunosorbent assay) is a widely used technique for detecting and quantifying specific proteins in biological samples. The Golimumab ELISA Kit is a powerful tool that utilizes this technique to detect and quantify golimumab in various biological samples, such as serum, plasma, and cell culture supernatants. Structure of the Golimumab ELISA Kit The Golimumab ELISA Kit consists of several components, including microtiter plates coated with a specific antibody against golimumab, golimumab standards, and detection reagents. The microtiter plates are pre-coated with the capture antibody, which specifically binds to golimumab. The standards are used to generate a standard curve for quantification of golimumab in the samples. The detection reagents include an enzyme-labeled golimumab and a substrate that produces a colorimetric signal when acted upon by the enzyme. The principle of the Golimumab ELISA Kit is based on the specific binding of golimumab to the capture antibody on the microtiter plate. Any golimumab present in the sample will bind to the capture antibody, while any unbound proteins are washed away. The enzyme-labeled golimumab is then added, which binds to the captured golimumab. The substrate is then added, and the color change is measured using a spectrophotometer. The intensity of the color is directly proportional to the amount of golimumab present in the sample, allowing for accurate quantification. Activity of the Golimumab ELISA Kit The Golimumab ELISA Kit has a high sensitivity and specificity for golimumab, meaning it can accurately detect and quantify very low levels of golimumab in biological samples. It has a wide dynamic range, allowing for the measurement of golimumab at various concentrations. The kit also has a high reproducibility, with low intra- and inter-assay variability. This ensures that results obtained from different experiments or different operators are consistent and reliable. The Golimumab ELISA Kit is also a rapid and convenient method for golimumab detection, with a total assay time of less than 4 hours. This makes it a valuable tool for high-throughput screening of samples in research and clinical settings. Application of the Golimumab ELISA Kit The Golimumab ELISA Kit has a wide range of applications in both research and clinical settings. It can be used to measure golimumab levels in patient samples to monitor treatment efficacy and guide dosing decisions. It is also a valuable tool for studying the pharmacokinetics of golimumab, as it allows for the measurement of drug levels in various biological matrices over time. In addition, the Golimumab ELISA Kit can be used in pre-clinical studies to assess the pharmacokinetics and immunogenicity of golimumab in animal models. It can also be used to measure golimumab levels in cell culture supernatants, which is useful for optimizing cell-based assays and studying the mechanism of action of golimumab. In Conclusion The Golimumab ELISA Kit is a
Host
Reactivity
Applications
Conjugation
Golimumab ELISA Kit, Abbexa, abx395018
Golimumab ELISA Kit is a quantitative ELISA kit for detection of Golimumab.Golimumab (Simponi®) is a human immunoglobulin G1 monoclonal antibody which is specific for pro-inflammatory cytokine, tumor necrosis factor-a (TNFa). In 2009, it was approved by FDA for the treatment of rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis in adult patients. Elevated levels of TNF are found in the synovial fluid of rheumatoid arthritis, including juvenile idiopathic arthritis, psoriatic arthritis, and ankylosing spondylitis patients and play an important role in both the pathologic inflammation and the joint destruction that are hallmarks of these diseases. Increased levels of TNF are also found in psoriasis (Ps) plaques. Golimumab binds to both the soluble and transmembrane bioactive forms of human TNF and prevent TNF from binding to its receptors and finally inhibits biological activity of TNF.
Host
Reactivity
Human
Applications
ELISA
Conjugation
Human Anti-Golimumab ELISA Kit, Abbexa, abx392368
Human Anti-Golimumab ELISA Kit is a quantitative ELISA kit for detection of antibodies against Golimumab.
Host
Reactivity
Human
Applications
ELISA
Conjugation
Please provide the required information below so that we can quickly source your products.